Xenon Pharmaceuticals, Inc. (XENE)
35.34
-1.16
(-3.18%)
USD |
NASDAQ |
Oct 23, 16:00
35.30
-0.04
(-0.11%)
After-Hours: 20:00
Xenon Pharmaceuticals Market Cap : 3.419B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.419B |
| October 22, 2026 | 3.531B |
| October 21, 2026 | 3.478B |
| October 20, 2026 | 3.509B |
| October 19, 2026 | 3.394B |
| October 16, 2026 | 3.240B |
| October 15, 2026 | 3.322B |
| October 14, 2026 | 3.280B |
| October 13, 2026 | 3.330B |
| October 12, 2026 | 3.465B |
| October 09, 2026 | 3.526B |
| October 08, 2026 | 3.499B |
| October 07, 2026 | 3.523B |
| October 06, 2026 | 3.538B |
| October 05, 2026 | 3.635B |
| October 02, 2026 | 3.679B |
| October 01, 2026 | 3.767B |
| September 30, 2026 | 3.598B |
| September 29, 2026 | 3.604B |
| September 28, 2026 | 3.553B |
| September 25, 2026 | 3.574B |
| September 24, 2026 | 3.682B |
| September 23, 2026 | 3.537B |
| September 22, 2026 | 3.782B |
| September 21, 2026 | 3.772B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.846B |
| September 17, 2026 | 5.549B |
| September 16, 2026 | 5.492B |
| September 15, 2026 | 5.445B |
| September 14, 2026 | 5.630B |
| September 11, 2026 | 5.675B |
| September 10, 2026 | 5.689B |
| September 09, 2026 | 5.706B |
| September 08, 2026 | 5.762B |
| September 04, 2026 | 5.781B |
| September 03, 2026 | 5.844B |
| September 02, 2026 | 5.821B |
| September 01, 2026 | 5.805B |
| August 31, 2026 | 5.826B |
| August 28, 2026 | 5.804B |
| August 27, 2026 | 5.992B |
| August 26, 2026 | 6.172B |
| August 25, 2026 | 5.846B |
| August 24, 2026 | 5.859B |
| August 21, 2026 | 5.880B |
| August 20, 2026 | 5.779B |
| August 19, 2026 | 6.030B |
| August 18, 2026 | 6.113B |
| August 17, 2026 | 6.034B |
| August 14, 2026 | 6.033B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Psyence Biomedical Ltd. | 9.552M |
| Aurinia Pharmaceuticals, Inc. | 2.241B |
| enGene Therapeutics, Inc. | 104.54M |
| Medicus Pharma Ltd. | 150.42M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
Market Cap Related Metrics
| PEG Ratio | -0.2199 |
| Price to Book Value | 2.752 |
| Price | 35.34 |
| Earnings Yield | -13.42% |
| PEGY Ratio | -0.2199 |